N/A
Manufactured by Best Choice (Valu Merchandisers Company)
389 FDA adverse event reports analyzed
Last updated: 2026-04-15
DEXTROMETHORPHAN HBR is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Best Choice (Valu Merchandisers Company). The most commonly reported adverse reactions for DEXTROMETHORPHAN HBR include DRUG ABUSE, CARDIAC ARREST, COMPLETED SUICIDE, RESPIRATORY ARREST, DEATH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for DEXTROMETHORPHAN HBR.
Out of 221 classified reports for DEXTROMETHORPHAN HBR:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 389 FDA FAERS reports that mention DEXTROMETHORPHAN HBR. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DRUG ABUSE, CARDIAC ARREST, COMPLETED SUICIDE, RESPIRATORY ARREST, DEATH, TOXICITY TO VARIOUS AGENTS. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Best Choice (Valu Merchandisers Company) in connection with DEXTROMETHORPHAN HBR. Always verify the specific product and NDC with your pharmacist.